Safety monitoring

Keywords:
#
BioJapan2022
#
JAK inhibitors
#
GlobalFemaleLeaders
#
GFL
#
EWMD
#
Arab Health 2022
#
Clinical Trial
No items found.
SCARLETRED used in Janus kinase inhibitor safety testing and monitoring
Article
•
Jun 6, 2022

SCARLETRED skin monitoring helps to make treatments with JAK inhibitors safer

With patient safety in mind, SCARLETRED®Vision can be used as a digital aid to measure and document treatment safety and efficacy of newly developed JAK inhibitors either on site and/or home based clinical trials.
Publication
•
September 27, 2021

The mathematics of erythema: Development of machine learning models for artificial intelligence assisted measurement and severity scoring of radiation induced dermatitis

Read more